Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$176.69
+0.1%
$164.95
$140.68
$181.16
$425.05B0.418.64 million shs5.95 million shs
Kenvue Inc. stock logo
KVUE
Kenvue
$20.78
-0.1%
$21.49
$19.75
$25.17
$39.90B0.8318.02 million shs16.47 million shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
-1.06%-0.60%+4.96%+15.80%+7.28%
Kenvue Inc. stock logo
KVUE
Kenvue
-1.86%-3.21%-8.96%-11.70%-5.31%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.8742 of 5 stars
2.35.04.23.94.01.71.9
Kenvue Inc. stock logo
KVUE
Kenvue
3.847 of 5 stars
3.23.02.50.03.11.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.65
Moderate Buy$176.29-0.23% Downside
Kenvue Inc. stock logo
KVUE
Kenvue
2.31
Hold$24.3817.32% Upside

Current Analyst Ratings Breakdown

Latest JNJ and KVUE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/21/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$185.00 ➝ $200.00
8/11/2025
Kenvue Inc. stock logo
KVUE
Kenvue
Zacks Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong Sell
8/8/2025
Kenvue Inc. stock logo
KVUE
Kenvue
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$29.00 ➝ $26.00
8/8/2025
Kenvue Inc. stock logo
KVUE
Kenvue
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$24.00 ➝ $22.00
7/25/2025
Kenvue Inc. stock logo
KVUE
Kenvue
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$27.00 ➝ $26.00
7/23/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy
7/17/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight
7/17/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$165.00 ➝ $176.00
7/17/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$181.00 ➝ $185.00
7/17/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$180.00 ➝ $190.00
7/17/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$164.00 ➝ $167.00
(Data available from 8/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$88.82B4.79$13.14 per share13.45$32.58 per share5.42
Kenvue Inc. stock logo
KVUE
Kenvue
$15.46B2.58$1.47 per share14.13$5.59 per share3.72
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$14.07B$9.3518.9015.962.2525.00%32.49%13.00%10/21/2025 (Estimated)
Kenvue Inc. stock logo
KVUE
Kenvue
$1.03B$0.7428.0816.762.999.37%20.06%7.78%11/6/2025 (Estimated)

Latest JNJ and KVUE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Kenvue Inc. stock logo
KVUE
Kenvue
$0.28$0.29+$0.01$0.22$3.94 billion$3.84 billion
7/16/2025Q2 2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.68$2.77+$0.09$2.29$22.85 billion$23.74 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.202.94%N/A55.61%64 Years
Kenvue Inc. stock logo
KVUE
Kenvue
$0.833.99%N/A112.16%1 Years

Latest JNJ and KVUE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/16/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.303.35%8/26/20258/26/20259/9/2025
7/30/2025
Kenvue Inc. stock logo
KVUE
Kenvue
quarterly$0.20753.74%8/13/20258/13/20258/27/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.50
1.01
0.76
Kenvue Inc. stock logo
KVUE
Kenvue
0.66
0.98
0.68

Institutional Ownership

CompanyInstitutional Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
Kenvue Inc. stock logo
KVUE
Kenvue
97.64%

Insider Ownership

CompanyInsider Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
Kenvue Inc. stock logo
KVUE
Kenvue
1.68%
CompanyEmployeesShares OutstandingFree FloatOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,1002.41 billion2.40 billionOptionable
Kenvue Inc. stock logo
KVUE
Kenvue
22,0001.92 billion1.89 billionOptionable

Recent News About These Companies

Kenvue (KVUE) Slid Due to Operational Challenges
Kenvue Inc. $KVUE Shares Sold by Bahl & Gaynor Inc.
CW Advisors LLC Grows Holdings in Kenvue Inc. $KVUE
Johnson and Johnson Building
JNJ Stock Surge Signals Confidence in New Growth Path (KVUE)
...
Kenvue Inc. $KVUE Shares Acquired by Allstate Corp
Norinchukin Bank The Increases Stake in Kenvue Inc. $KVUE
Head-To-Head Comparison: Kenvue (NYSE:KVUE) vs. ARKO (NASDAQ:ARKO)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$176.69 +0.20 (+0.11%)
Closing price 03:59 PM Eastern
Extended Trading
$177.28 +0.59 (+0.33%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Kenvue stock logo

Kenvue NYSE:KVUE

$20.78 -0.01 (-0.06%)
Closing price 03:59 PM Eastern
Extended Trading
$20.80 +0.03 (+0.13%)
As of 06:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.